Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort (CoEnv)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT01314547
First received: March 11, 2011
Last updated: October 12, 2012
Last verified: November 2010

March 11, 2011
October 12, 2012
March 2005
December 2011   (final data collection date for primary outcome measure)
Score on a disease activity rating scale [ Time Frame: Six years ] [ Designated as safety issue: No ]
Score on a disease activity rating scale (quaterly,than monthly basis)
Same as current
Complete list of historical versions of study NCT01314547 on ClinicalTrials.gov Archive Site
Ancillary studies will be possible with the available database [ Time Frame: six years ] [ Designated as safety issue: No ]
Ancillary studies will be possible with the available database
Same as current
Not Provided
Not Provided
 
Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort
Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort

Susceptibility to SPA has been shown to be largely genetically determined. The objective of this study was to prospectively investigate the impact of several environmental factors on disease activity.

Susceptibility to SPA has been shown to be largely genetically determined but the contribution of environmental factors to disease evolution has not yet been elucidated. The objective of this study was to prospectively investigate the impact of several environmental factors on disease activity.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

patients with SPA disease

  • Spondylarthritis
  • Primary Systemic Vasculitis
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
300
December 2011
December 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years SPONDILARTHRITIS: modified New York criteria Systemic vasculitis: ACR criteria

Exclusion Criteria:

no internet access

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT01314547
AOM02020
No
Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
Not Provided
Principal Investigator: THOMAS HANSLIK, PU-PH Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
November 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP